# \[e-drug\] UNITAID releases first HIV Medicines Technology and Market Landscape

**URL:** <https://talk.edrugplus.org/t/e-drug-unitaid-releases-first-hiv-medicines-technology-and-market-landscape/40335>\
**Category:** e-drug\
**Created:** [April 5, 2014, 5:23am UTC](https://talk.edrugplus.org/t/e-drug-unitaid-releases-first-hiv-medicines-technology-and-market-landscape/40335 "2014-04-05T05:23:00Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![BLUMER\_Katherine](https://avatars.discourse-cdn.com/v4/letter/b/f05b48/32.png) [@BLUMER\_Katherine](https://talk.edrugplus.org/u/BLUMER_Katherine)\
**Post date:** [April 5, 2014, 5:23am UTC](https://talk.edrugplus.org/t/e-drug-unitaid-releases-first-hiv-medicines-technology-and-market-landscape/40335/1 "2014-04-05T05:23:00Z")

</div>

E-DRUG: UNITAID releases first HIV Medicines Technology and Market Landscape  
-------------------------------------------------------------------------------------------------------------

UNITAID has released its first \_HIV Medicines Technology and Market  
Landscape \_  
\<[http://www.unitaid.eu/images/marketdynamics/publications/HIV-Meds-Landscape-March2014.pdf&gt](http://www.unitaid.eu/images/marketdynamics/publications/HIV-Meds-Landscape-March2014.pdf&gt);

This comprehensive study reviews access to antiretroviral therapy (ART)  
in low and middle- income countries based on extensive medicine  
technology and market analyses and highlights critical market  
shortcomings, underlying reasons for market failures and potential  
approaches to correcting them.

For more information on the UNITAID HIV Medicines Technology and Market  
Landscape, please contact Katherine Blumer \<blumerk@unitaid.who.int\>

Katherine BLUMER | Technical Officer | UNITAID  
blumerk@unitaid.who.int